When a new treatment becomes available for a particular health condition, such as a new medication to treat a disease, it’s tested to see whether it’s effective for its intended purpose. It’s also tested for potential side effects. This is done through a series of human trials, known as clinical trials.
Not every drug designed by pharmaceutical companies makes it to the market; very few do. Only 9.6% of new drugs in development in the years 2006-2015 successfully made it to the market to be used by patients. That’s because there’s quite a process a drug needs to go through to make sure it’s not only effective for what it’s designed for, but that it’s not harmful.
Online geriatric assessments are as reliable as face-to-face decisions when geriatricians consider the suitability of residential care for older hospital patients, a study has found.
The University of Queensland has been awarded almost $7.5 million to accelerate improvements in the prevention, diagnosis, treatment and management of dementia.
Professor Peter Yellowlees has been announced as the keynote speaker at Successes and Failures in Telemedicine (SFT-17) – being held in Brisbane from 30-31 October, 2017.